Analyzing the genetic profiles of head and neck tumors
Official title: Molecular and Genomic Profiling of Head and Neck Tumors to Explore Biomarkers Associated With Prognosis and Response to Therapy
Run by Montefiore Medical Center · NCT00200486 · Data updated 2026-11-12
This study is trying to see if looking at the genes in head and neck tumors can help predict how well patients will respond to treatment and their overall outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Montefiore Medical Center Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (The Bronx, New York) |
| Status | Recruiting |
| Started | October 1, 2002 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT00200486 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with actual or suspected malignant or non-malignant tumors of the head and neck who are undergoing biopsy or resection.
✕Probably not a fit
Patients with insufficient tissue available for both standard diagnostic evaluation and study specimen will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the genetic profiles of head and neck tumors and their correlation with treatment responses and patient outcomes. Utilizing genetic microarray analysis, the research identifies distinct gene expression patterns that may serve as better predictors of prognosis compared to traditional clinical variables. The study focuses on isolating specific genes that change expression during tumor progression and metastasis, providing insights into the malignant transformation process. By analyzing tumor samples, the study seeks to enhance understanding of how genetic factors influence cancer behavior and treatment efficacy.
Why it matters
Potential benefit: If successful, this study could lead to improved prognostic tools and personalized treatment strategies for patients with head and neck cancer.
How similar studies have gone: Previous studies using genetic profiling in similar contexts have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * actual or suspected malignant or non-malignant tumors of the head and neck * planned biopsy and/or resection, or availability of paraffin embedded or stored frozen tumor tissue for non-genetic analysis Exclusion Criteria: * insufficient tissue available for both standard diagnostic evaluation and study specimen
Where it's running
-
Stelby Augustine
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Richard V Smith, MD — Montefiore Medical Center
- Study coordinator: Stelby Augustine, RN
- Email: staugust@montefiore.org
- Phone: 718-920-7054
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longer antibiotic prophylaxis after head and neck cancer surgery
This trial tests whether giving antibiotics for 7 days after major mouth and throat cancer surgery reduces wound infections compared with the standard 24-hour course.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Topical Boswellia 2% Cream to Prevent Radiation Dermatitis in Head and Neck Cancer
A topical 2% Boswellia serrata cream is tested to see if it can prevent skin irritation from radiation in people with head and neck cancer.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT
This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.
-
Ozone gas plus biomimetic toothpaste and mouthwash to treat cancer therapy mouth sores
This trial will test whether adding a biomimetic toothpaste and mouthwash to ozone gas therapy helps adults with chemo- or radiotherapy-induced mouth sores heal faster and have less pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.